Cure Ventures harnesses its team's skills and decades of company-building experience to create innovative companies that aim to eradicate diseases by focusing on de novo company formation built around bold ideas and visionary entrepreneurs.
Cure Ventures will provide the right level of human and financial capital that is required at each stage of the company's life. We seek to build great companies around pioneering scientific solutions with strong intellectual property positions. The Cure Ventures team intends to focus on disruptive technologies that target high unmet patient needs.
The optimal company build will exhibit a clear genetic validation, substantiated and rigorously derived scientific data. the provenance of a distinguished scientific laboratory, biology with mechanistic clarity, multiple commercial applications, large uncrowded markets, expedited clinical routes, string partnering interest from large pharmaceutical companies, and an articulable oath to an exit.